EPAS1-related pheochromocytoma/paraganglioma
Endocrine-Related Cancer · 20.05.2024 · 31 (8)
DOI: 10.1530/erc-23-0303 ↗Kurz gefasst
Fallbericht in der Zeitschrift Endocrine-Related Cancer, erschienen am 20.05.2024. Verfasst von Ali S Alzahrani und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia. Hauptthemen laut MEDLINE: Adrenal Gland Neoplasms, Basic Helix-Loop-Helix Proteins, Paraganglioma, Pheochromocytoma. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 57 Literaturangaben.
Abstract (Originalsprache)
In 2012, somatic EPAS1 pathogenic variants were found to cause a triad of pheochromocytoma/paragangliomas (PPGLs), polycythemia, and somatostatinoma. Since then, a limited number of studies on this subject have been reported, and data on the long-term outcome of metastatic disease are not available on this rare syndrome. We comprehensively reviewed EPAS1 -related PPGL and describe an unusual patient who has been living with an EPAS1 -related metastatic PPGL for 47 years. The results of this work show that EPAS1 pathogenic variants are rare, more in females and patients without pathogenic variants in other PPGL susceptibility genes. PPGLs are the most common manifestation followed by polycythemia and somatostatinoma. The EPAS1 pathogenic variants are often postzygotic, and the timing of their acquirement during embryonic development seems to correlate with the number and timing of development of the disease manifestations. Although recurrent and multifocal disease is common in EPAS1 -related PPGL, distant metastases are uncommon and usually indolent. This is illustrated by a case of a man who was diagnosed at the age of 9 years and is currently 56 years old, alive, and well for 47 years with these metastases. He was found to have a somatic EPAS1 pathogenic variant (c.1592C>A, p.Pro531His) in bilateral pheochomocytoma and a pancreatic NET (somatostatinoma) but not in genomic DNA isolated from peripheral leukocytes. This and previous reports suggest that distant metastases are uncommon and less aggressive in EPAS1 -related PPGLs compared to those found in other hereditary PPGLs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia.
- Department of Molecular Oncology, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia.
- Université Paris Cité, Inserm, Paris Centre de Recherche Cardiovasculaire (PARCC), Equipe Labellisée Ligue contre le Cancer, Paris, France.
- Département de Médecine Génomique des Tumeurs et des Cancers, Fédération de Génétique et de Médecine Génomique, Assistance Publique-Hôpitaux de Paris (AP-HP) Centre, Hôpital Européen Georges Pompidou, Paris, France.
- Department of Pathology and Laboratory Medicine, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia.
- Section on Medical Neuroendocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland, USA.
Zitieren
APA
Alzahrani, A. S., Alswailem, M., Buffet, A., Alghamdi, B., Alobaid, L., Alsagheir, O., Al-Hindi, H., & Pacak, K. (2024). EPAS1-related pheochromocytoma/paraganglioma. Endocrine-Related Cancer, 31(8). https://doi.org/10.1530/erc-23-0303
Vancouver
Alzahrani AS, Alswailem M, Buffet A, Alghamdi B, Alobaid L, Alsagheir O, et al. EPAS1-related pheochromocytoma/paraganglioma. Endocrine-Related Cancer. 2024;31(8). doi:10.1530/erc-23-0303
BibTeX
@article{Alzahrani2024,
author = {Alzahrani, Ali S and Alswailem, Meshael and Buffet, Alexandre and Alghamdi, Balgees and Alobaid, Lulu and Alsagheir, Osamah and Al-Hindi, Hindi and Pacak, Karel},
title = {EPAS1-related pheochromocytoma/paraganglioma},
journal = {Endocrine-Related Cancer},
year = {2024},
volume = {31},
number = {8},
doi = {10.1530/erc-23-0303}
}
EUVIMED